Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Should Scrap Manufacturing Changes Proposed Rule, Guidance - PhRMA

Executive Summary

FDA's proposed rule "Supplements and Other Changes to an Approved Application" and its accompanying guidance should be abandoned, the Pharmaceutical Research & Manufacturers of America asserted in Aug. 27 comments to the agency.

You may also be interested in...



Industry Requests Decreased Filing Burden For Improved Analytical Methods

FDA should consider a decreased filing burden for improved post-approval analytical methods, industry participants contended at a recent FDA/American Association of Pharmaceutical Scientists workshop on packaging and analytical methods post-approval changes.

Industry Requests Decreased Filing Burden For Improved Analytical Methods

FDA should consider a decreased filing burden for improved post-approval analytical methods, industry participants contended at a recent FDA/American Association of Pharmaceutical Scientists workshop on packaging and analytical methods post-approval changes.

Packaging Component List For Approved Drugs Could Ease PAC Filings

FDA and the pharmaceutical industry should draft a list of "CDER-approved" container closure components as a supplement to the upcoming packaging post-approval changes guidance, participants recommended at an FDA/American Association of Pharmaceutical Scientists workshop on packaging and analytical method post-approval changes.

Related Content

UsernamePublicRestriction

Register

OM017301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel